Page 1 of Clinical Trials for Drug Aliskiren 150 300 mg, 62 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics
Last Updated: March 29, 2010
Condition(s): Diabetes Mellitus
2
Terminated
Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome
Last Updated: April 26, 2011
Condition(s): Hypertension With Metabolic Syndrome
3
Recruiting
Direct Renin Inhibition Effects on Atherosclerotic Biomarkers
Last Updated: March 3, 2011
Condition(s): Coronary Artery Disease; Type 2 Diabetes Mellitus
4
Recruiting
Trial to Evaluate the Effect of Tektura (Aliskiren), Angiotensin Inhibitors, Diuretics, and Calcium Channel Blockers on Coronary Flow Reserve in Patients With Type II Diabetes and Hypertension
Last Updated: April 2, 2011
Condition(s): Hypertension; Diabetes Mellitus, Non-Insulin-Dependent
5
Completed
Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension
Last Updated: June 2, 2011
Condition(s): Hypertension
6
Completed
A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly
Last Updated: February 28, 2011
Condition(s): Hypertension
7
Recruiting
Vitamin D Deficiency in Patients With Hypertension
Last Updated: December 14, 2011
Condition(s): Vitamin D Deficiency; Hypertension
8
Completed
A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.
Last Updated: November 7, 2011
Condition(s): Hypertension
9
Completed
Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension
Last Updated: May 20, 2011
Condition(s): Hypertension; Left Ventricular Hypertrophy; Overweight
10
Recruiting
A Clinical Study With Aliskiren Alone or in Combination Therapy With Diuretic Hctz in Venezuelan Hypertensive Patients.
Last Updated: August 23, 2011
Condition(s): High Blood Pressure
11
Completed
Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
Last Updated: February 28, 2011
Condition(s): Hypertension
12
Completed
A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg
Last Updated: February 24, 2011
Condition(s): Hypertension
13
Completed
Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study
Last Updated: June 24, 2011
Condition(s): Hypertension
14
Completed
Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise
Last Updated: June 2, 2011
Condition(s): Hypertension
15
Completed
Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension
Last Updated: November 7, 2011
Condition(s): Hypertension
16
Completed
Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension.
Last Updated: June 24, 2011
Condition(s): Essential Hypertension
17
Completed
Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal
Last Updated: June 22, 2011
Condition(s): Hypertension
18
Recruiting
Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension
Last Updated: January 27, 2012
Condition(s): Hypertension
19
Completed
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
Last Updated: April 7, 2011
Condition(s): Hypertension
20
Completed
Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension
Last Updated: April 15, 2011
Condition(s): Hypertension

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Aliskiren+150+300+mg

Page 1 of Clinical Trials for Drug Aliskiren 150 300 mg, 62 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About